$2.27B
$36.8 Million
0.0% of portfolio
1,070,708
Q2 2025
Added 19.53%
$782M
$7.82 Million
0.0% of portfolio
272,336
Q2 2025
Reduced 2.7%
$140M
$106,000
0.0% of portfolio
11,766
Q2 2025
Added 23.24%
$0
$1.41 Million
0.0% of portfolio
225,041
Q2 2025
Added 14.49%
-
$0
0.0% of portfolio
-
Q2 2025
New
$789M
$22.5 Million
0.0% of portfolio
1,614,130
Q2 2025
Reduced 11.48%
$123M
$990,000
0.0% of portfolio
276,601
Q2 2025
Added 105.71%
$0
$0
0.0% of portfolio
1
Q1 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 19.67%
$1.28B
$8.3 Million
0.0% of portfolio
363,587
Q2 2025
Reduced 2.74%
$1.51B
$15.6 Million
0.0% of portfolio
201,637
Q2 2025
Added 4.56%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 50.0%
-
$0
0.0% of portfolio
-
Q2 2025
Added 223.83%
$6.84B
$1.75 Million
0.0% of portfolio
71,796
Q2 2025
Added 29.68%
$0
$79,000
0.0% of portfolio
15,139
Q2 2025
Reduced 11.54%
$0
$9,000
0.0% of portfolio
205
Q3 2024
New
$236M
$1.97 Million
0.0% of portfolio
73,405
Q2 2025
Reduced 3.79%
$6.05B
$32.1 Million
0.0% of portfolio
1,127,054
Q2 2025
Added 4.15%
$0
$16.8 Million
0.0% of portfolio
395,072
Q2 2025
Added 44.4%
$146M
$77,000
0.0% of portfolio
6,629
Q2 2025
Added 3,102.42%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 16.67%
-
$0
0.0% of portfolio
-
Q2 2025
Added 1,570.65%
$395M
$5.29 Million
0.0% of portfolio
1,055,668
Q2 2025
Reduced 3.3%
$0
$26.7 Million
0.0% of portfolio
1,757,417
Q2 2025
Reduced 23.04%
$78.2M
$8,000
0.0% of portfolio
4,625
Q3 2024
Reduced 95.33%
-
$0
0.0% of portfolio
-
Q2 2025
Added 180.83%
$44.4M
$49,000
0.0% of portfolio
117,465
Q2 2025
Reduced 67.23%
-
$0
0.0% of portfolio
-
Q1 2025
Added 8.08%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 13.21%
$99.7M
$467,000
0.0% of portfolio
105,503
Q2 2025
Added 68.65%
$43.6M
$230,000
0.0% of portfolio
284,382
Q2 2025
Reduced 6.08%
$0
$28,000
0.0% of portfolio
548
Q2 2025
Reduced 5.52%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 10.63%
$2.02B
$27.1 Million
0.0% of portfolio
1,346,345
Q2 2025
Added 66.92%
-
$0
0.0% of portfolio
-
Q2 2025
Added 0.3%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Added 10.56%
First Tr Exchng Traded Fd Vi
-
$0
0.0% of portfolio
-
Q4 2024
New
$57.4M
$32,000
0.0% of portfolio
11,977
Q2 2025
Reduced 57.1%
$6.26B
$41.8 Million
0.0% of portfolio
535,913
Q2 2025
Reduced 32.21%
$0
$12 Million
0.0% of portfolio
145,803
Q2 2025
Reduced 1.24%
$2B
$18 Million
0.0% of portfolio
1,096,043
Q2 2025
Added 135.37%
$0
$29.6 Million
0.0% of portfolio
1,300,655
Q2 2025
Reduced 0.18%
$0
$91,000
0.0% of portfolio
1,404
Q2 2025
Added 6.85%
$1.13B
$6.18 Million
0.0% of portfolio
102,017
Q2 2025
Added 3.28%
$341M
$170,000
0.0% of portfolio
137,492
Q2 2025
Reduced 51.9%
$5.33B
$22.5 Million
0.0% of portfolio
542,852
Q2 2025
Added 29.93%
$0
$72,000
0.0% of portfolio
2,046
Q2 2025
Added 95.79%
Tortoise Capital Series Trus
-
$0
0.0% of portfolio
-
Q2 2025
New
$0
$56,000
0.0% of portfolio
15,514
Q2 2025
Reduced 77.75%